Heat thErapy And mobiLity in COVID-19 Survivors
ConditionLong COVID
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-90
SponsorUniversity of Nebraska
About this trial
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Eligibility criteria
Qualifiers
Between the ages of 50 and 90 years
Free from orthopedic limitations that would prohibit performing leg exercise
BMI < 40 kg/m2 and weigh < 400lbs
Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following SARS-CoV-2 infection
Disqualifiers
Unable to give written informed consent
Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
Women who are taking hormone therapy
Claustrophobia
Trial design
Treatments tested in this trial
- Heat therapy
- Sham Control
- Walking
Treatment groups
99 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Nebraska
Lead sponsor
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov